Male LEW.1WR1 Rats Develop Metabolic Dysfunction, Steatohepatitis, and Liver Damage
Authors:
- Quiana C. Wilkerson-VidalQuiana C. Wilkerson-Vidal
- Madushika M. WimalarathneMWMadushika M. Wimalarathne
- Emily C. HuntEHEmily C. Hunt
- Luis MercadoLMLuis Mercado
- Moses Adaji DavidMoses Adaji David
- Christopher R. AppersonCAChristopher R. Apperson
- Alan SmileyASAlan Smiley
- Sharifa Tahirah Love-RutledgeSLSharifa Tahirah Love-Rutledge
- Bernhard W. G. VoglerBVBernhard W. G. Vogler
Open Access
- 19 April 2024
- journal article
- research article
- Published by MDPI AG in Endocrines
- Vol. 5 (2) , 166-185
Abstract
Most patients with non-alcoholic steatohepatitis (NASH) have insulin resistance, and there is a near-universal association between NASH and insulin resistance. Insulin resistance induces lipid accumulation in the liver, leading to the development of metabolic syndrome. However, most NASH rodent models fail to develop metabolic syndrome. LEW.1WR1 rats that are 23 weeks old showed increased body mass, epididymal fat, and liver mass, suggesting obesity-driven metabolic dysfunction. We have characterized steatosis, inflammation, Mallory–Denk body formation with hematoxylin and eosin (H&E), and fibrosis with Trichome blue staining. The presence of hepatic fibrosis with other features of NASH described above is one of the major strengths of this model since most of the currently available NASH models do not develop microvesicular steatosis or fibrosis. Together with the other important features of NASH described above, we confirm that male LEW.1WR1 rats develop NASH and insulin resistance with a standard diet.Keywords
Funding Information
- The University of Alabama in Huntsville, the Louis Stokes Alliance for Minority Participation (1619659, NSF)
- American Association of University Women (1619659, NSF)
This publication has 55 references indexed in Scilit:
- Metabolite quantification: A fluorescence-based method for urine sample normalization prior to 1H-NMR analysisMetabolomics, 2022
- Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin ResistanceHepatology Communications, 2019
- Evaluation of sample preparation protocols for quantitative NMR-based metabolomicsMetabolomics, 2019
- Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitisHepatology, 2013
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver diseaseHepatology, 2013
- Hypoxia and Hypoxia Inducible Factors: Diverse Roles in Liver DiseasesHepatology, 2011
- TGF-β in progression of liver diseaseCell and tissue research, 2011
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Inhibited Activities in CCAAT/Enhancer-Binding Protein, Activating Protein-1 and Cyclins after Hepatectomy in Rats with Thioacetamide-Induced Liver CirrhosisBiochemical and Biophysical Research Communications, 2002
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985